Avant Technologies and Ainnova Begin Designing Clinical Trial Protocol for Company’s Vision AI Platform
Avant Technologies Inc. (OTCQB:AVAI) (”Avant” or the “Company”), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease ...
Clinical Trials Arena on MSN7d
FDA aligns with Imunon’s Phase III trial protocol for ovarian cancer treatment
Imunon is initiating sites for the trial and collaborating with investigators to commence participant enrolment.
Skye Bioscience accelerates nimacimab clinical trial timeline with early enrollment and extended treatment period
Q4 2024 Management View CEO Punit Dhillon highlighted significant progress with the clinical development of nimacimab, including the completion of patient enrollment for the CBeyond Phase IIa trial ...
Raleigh News & Observer7d
Avant Technologies and Ainnova Begin Designing Clinical Trial Protocol for Company’s Vision AI Platform
Ainnova has hired an ophthalmologist, who is assisting in drafting the requirements for the clinical trial protocol that the Company's Contract Research Organization (CRO), Fortrea, has requested.
Morningstar7d
Avant Technologies and Ainnova Begin Designing Clinical Trial Protocol for Company's Vision AI Platform
Ainnova has hired an ophthalmologist, who is assisting in drafting the requirements for the clinical trial protocol that the Company's Contract Research Organization (CRO), Fortrea, has requested.